• Ultragenyx Pharmaceutical 2023 shares outstanding were 0.074B, a 5.19% increase from 2022.
• Ultragenyx Pharmaceutical 2022 shares outstanding were 0.07B, a 3.12% increase from 2021.
• Ultragenyx Pharmaceutical 2021 shares outstanding were 0.068B, a 11.42% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.